13 Best Penny Stocks to Buy According to Billionaire Ken Griffin
In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin.
Kezar Life Sciences Inc. (KZR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 716,759 | $4,508,414 | 0.09% | |
| 2. | Tang Capital Management Kevin C. Tang | 664,314 | $4,178,535 | -8% | 0.21% |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 276,754 | $1,740,783 | 0.06% | |
| 4. | Stonepine Capital Timothy P. Lynch | 156,179 | $982,366 | -60% | 0.72% |
| 5. | Renaissance Technologies Jim Simons | 131,285 | $825,783 | +14% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.77 | 20,000 | $295,400.00 | 890,691 | 2022-03-21 | Filing | |
| $17.00 | 45,000 | $765,000.00 | 870,691 | 2022-03-18 | Filing | |
| $15.96 | 15,000 | $239,400.00 | 825,691 | 2022-03-18 | Filing | |
| $10.19 | 750 | $7,642.50 | 11,320 | 2019-05-30 | Filing | |
| $5.50 | 1,454,545 | $7,999,997.50 | 6,254,545 | 2020-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.28 | 264 | $1,129.92 | 2,711 | 2025-07-02 | Filing | |
| $4.28 | 561 | $2,401.08 | 2,739 | 2025-07-02 | Filing | |
| $0.58 | 6,688 | $3,879.04 | 33,007 | 2024-07-02 | Filing | |
| $6.88 | 40,000 | $275,320.00 | 5,447,993 | 2023-02-06 | Filing | |
| $7.15 | 25,000 | $178,650.00 | 5,487,993 | 2023-02-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 720,787 | $5,348,240 | 3.43% | |
| 2. | 290,529 | $2,155,725 | 0% | |
| 3. | 126,692 | $924,520 | 0.76% | |
| 4. | 80,335 | $596,086 | 0.46% | |
| 5. | 53,600 | $397,712 | 0.03% |
News See All
12 Best Penny Stocks to Buy Under $1
Investors are optimistic as we move into the third quarter earnings season.
5 Best Biotech Stocks Under $10
In this article, we will look at the 5 best biotech stocks under $10.
5 Best Biotech Stocks Under $10
Avidity Partners Management is the largest shareholder in Nuvation Bio Inc. (NYSE:NUVB). For the second quarter, Nuvation Bio Inc.
10 Stocks to Invest in Under $20 According to Michael Castor's Sio Capital
In this piece, we will take a look at the ten stocks to invest in under $20 according to Sio Capital.
10 Pharmaceutical Stocks to Buy According to Lawrence Hawkins' Prosight Capital
In this article, we discuss 10 pharmaceutical stocks to buy according to Lawrence Hawkins' Prosight Capital.
Is KZR A Good Stock To Buy Now?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Kezar Life Sciences, Inc. (KZR): Hedge Funds In Wait-and-See Mode
In this article we will take a look at whether hedge funds think Kezar Life Sciences, Inc. (NASDAQ:KZR) is a good investment right now.
Hedge Fund and Insider Trading News: Bill Ackman, Jana Partners, CF Partners Capital Management, Stevens Capital Management, FibroGen Inc (FGEN), LPL Financial Holdings Inc (LPLA), and More
Apollo Global Management is suing private equity firm Advent International in a dispute over how to financially restructure the Advent-owned Serta Simmons Bedding, the largest mattress maker in the US...
Hedge Funds Are Selling Kezar Life Sciences, Inc. (KZR)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Fund Resource Center